Biogen proposes to buy remaining stake in Sage in $442 million deal
(Reuters) - Drugmaker Biogen (NASDAQ: BIIB ) will buy all outstanding shares of Sage Therapeutics that it does not already own for $7.22 apiece, a filing showed on Friday, sending the ...
US supports Musk argument in OpenAI lawsuit
By Jody Godoy (Reuters) -U.S. antitrust enforcers weighed in on Friday on Elon Musk's lawsuit seeking to block OpenAI's conversion to a public company, pointing out legal doctrines that sup...
TSMC begins producing 4-nanometer chips in Arizona, Raimondo says
WASHINGTON (Reuters) -Taiwan Semiconductor Manufacturing Co has begun producing advanced 4-nanometer chips for U.S. customers in Arizona, Commerce Secretary Gina Raimondo told Reuters, a mileston...
